Filter News
Area of Research
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (47)
- Clean Energy (57)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (27)
- Fusion Energy (7)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (23)
- Materials for Computing (5)
- National Security (7)
- Neutron Science (18)
- Nuclear Science and Technology (19)
- Quantum information Science (1)
- Supercomputing (52)
News Type
News Topics
- (-) Advanced Reactors (18)
- (-) Biomedical (45)
- (-) Coronavirus (34)
- (-) Frontier (38)
- (-) Fusion (43)
- (-) Mathematics (6)
- (-) Space Exploration (15)
- (-) Sustainable Energy (74)
- 3-D Printing/Advanced Manufacturing (81)
- Artificial Intelligence (75)
- Big Data (30)
- Bioenergy (74)
- Biology (80)
- Biotechnology (18)
- Buildings (31)
- Chemical Sciences (51)
- Clean Water (15)
- Climate Change (70)
- Composites (15)
- Computer Science (139)
- Critical Materials (13)
- Cybersecurity (31)
- Decarbonization (64)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (69)
- Environment (137)
- Exascale Computing (34)
- Fossil Energy (5)
- Grid (38)
- High-Performance Computing (69)
- Hydropower (5)
- Isotopes (45)
- ITER (4)
- Machine Learning (35)
- Materials (100)
- Materials Science (94)
- Mercury (9)
- Microelectronics (3)
- Microscopy (36)
- Molten Salt (3)
- Nanotechnology (42)
- National Security (53)
- Net Zero (11)
- Neutron Science (96)
- Nuclear Energy (80)
- Partnerships (43)
- Physics (52)
- Polymers (20)
- Quantum Computing (29)
- Quantum Science (56)
- Renewable Energy (2)
- Security (22)
- Simulation (38)
- Software (1)
- Statistics (2)
- Summit (50)
- Transformational Challenge Reactor (7)
- Transportation (52)
Media Contacts
Experts at the Department of Energy’s Oak Ridge National Laboratory are now offering short-term technical and scientific assistance to entities working to combat the coronavirus through the COVID-19 Technical Assistance Program, an initiative of DOE’s Office of Technology Transitions.
The Department of Energy announced awards for 10 projects with private industry that will allow for collaboration with DOE national laboratories in accelerating fusion energy development.
The inside of future nuclear fusion energy reactors will be among the harshest environments ever produced on Earth. What’s strong enough to protect the inside of a fusion reactor from plasma-produced heat fluxes akin to space shuttles reentering Earth’s atmosphere?
Oak Ridge National Laboratory researchers have designed and additively manufactured a first-of-its-kind aluminum device that enhances the capture of carbon dioxide emitted from fossil fuel plants and other industrial processes.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
Joe Hagerman, ORNL research lead for buildings integration and controls, understands the impact building technology innovations can have during times of crisis. Over a decade ago, he found himself in the middle of one of the most devastating natural disasters of the century, Hurricane Katrina.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Lithium, the silvery metal that powers smart phones and helps treat bipolar disorders, could also play a significant role in the worldwide effort to harvest on Earth the safe, clean and virtually limitless fusion energy that powers the sun and stars.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.